209984-58-7 Usage
Uses
Used in Pharmaceutical Industry:
LY-411575 (isoMer 1) is used as a therapeutic agent for the treatment of Alzheimer's disease due to its ability to inhibit the production of amyloid-beta peptides, which are implicated in the pathogenesis of the disease.
Used in Neurodegenerative Disorder Research:
In the field of neurodegenerative disorder research, LY-411575 (isoMer 1) is utilized as a research tool to study the role of gamma-secretase in the development of Alzheimer's disease and to explore its potential as a treatment for other related disorders.
Used in Drug Development:
LY-411575 (isoMer 1) is employed in drug development as a lead compound for the creation of new medications targeting the inhibition of gamma-secretase, aiming to provide novel treatment options for Alzheimer's disease and potentially other neurodegenerative conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 209984-58-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,9,8 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 209984-58:
(8*2)+(7*0)+(6*9)+(5*9)+(4*8)+(3*4)+(2*5)+(1*8)=177
177 % 10 = 7
So 209984-58-7 is a valid CAS Registry Number.
209984-58-7Relevant academic research and scientific papers
A multigram chemical synthesis of the γ-secretase inhibitor LY411575 and its diastereoisomers
Fauq, Abdul H.,Simpson, Katherine,Maharvi, Ghulam M.,Golde, Todd,Das, Pritam
, p. 6392 - 6395 (2008/09/16)
An improved chemical synthesis of N-2((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-l-alaninamide (LY411,575, 9a), a known γ-secretase inhibitor, is described. The key synthetic steps, which